Latest Announcements

Thirumalai Chemicals Limited's credit rating has been revised by ICRA Limited, with the long-term fund-based rating downgraded to BBB (Negative) and the short-term non-fund-based rating downgraded to A3+. The downgrade factors in the significant increase in US project cost and the extension in the project timeline.

Valecha Engineering Limited has informed the Exchange regarding 'Updates'. The company has approved the appointment of Ms. Sheuli Sandeep Mujharjee as Non-Executive & Independent Director, and the reappointment of M/s. Jain Jagawat Kamdar & Co as Statutory Auditors for the financial year 2026-27. The company has also approved the appointment of M/s. PAMSP & Associate Chartered Accountant as Internal Auditor for the financial year 2026-27. The unaudited financial results for the quarter ended 30th June, 2026 are presented.

Exato Technologies Ltd has announced the outcome of its board meeting dated August 13, 2026. The board considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also approved the proposal for reduction of share capital of its wholly-owned subsidiary Exato Technologies Pty. Ltd. in Australia, subject to obtaining necessary approvals. The 9th Annual General Meeting will be held on September 28, 2026, through video conference.

Supriya Lifescience Ltd. has reported a 31% YoY revenue growth in Q1 FY27, with revenues standing at Rs 189.75 crore compared to Rs 145.07 crore in Q1 FY26. The company's EBITDA margin stood at 25.0%, with a PAT of Rs 24.04 crore and a PAT margin of 12.7%.

Galaxy Surfactants Limited has informed the Exchange about Investor Presentation for Unaudited Financial Results for the quarter ended June 30, 2026. The presentation highlights the company's performance, key developments, and future prospects. The company's EBITDA grew 87% YoY to ₹252 Cr, driven by disciplined pricing, a favourable product mix, operational excellence, and improved operating leverage.

Supriya Lifescience Ltd reported a 31% YoY revenue growth in Q1 FY27, with revenue of Rs 189.75 crore, and a PAT of Rs 24.04 crore. The company's EBITDA margin declined to 25.0% in Q1 FY27 from 35.6% in Q1 FY26.

Krsnaa Diagnostics Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Reports as issued by the statutory auditors of the Company. The Board of Directors has also approved the issuance of 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited (Promoter and Promoter Group) at an issue price determined in future, which would be higher of the floor price as on the relevant date in the future as determined in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 or Rs. 565/-.

Bilcare Ltd has announced unaudited financial results for the quarter ended June 30, 2026, with a net profit of ₹1.04 crores and a basic EPS of ₹0.44. The company has also announced the appointment of new directors, including Mr. Mohan Bhandari as an Executive Director, and the resignation of Mr. Sagar R. Baheti as Company Secretary and Compliance Officer. Additionally, the company has announced the voluntary winding up of its subsidiary, Bilcare INC, in the United States.

AJR Infra And Tolling Limited has informed the Exchange regarding the outcome of the Board Meeting for the quarter ended June 30, 2026, where the Board approved the unaudited standalone and consolidated financial results, appointed internal auditors, and authorized key managerial personnel to determine materiality of events and make disclosures.

Krsnaa Diagnostics Ltd has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations at INR 2,355.32 million, a 22.4% increase from the same period last year. The company has also declared a final dividend of INR 2.00 per share for the financial year 2024-25. Additionally, the board has approved the issuance of 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited at a future determined price, which will be higher of the floor price as on the relevant date or INR 565.

Bilcare Ltd has announced the resignation of its Company Secretary, Compliance Officer, and Key Managerial Personnel, Sagar R. Baheti, effective August 13, 2026. The company has also appointed Mayur Dave as the new Company Secretary, Compliance Officer, and Key Managerial Personnel. Additionally, the company has approved the unaudited financial results for the quarter ended June 30, 2026, and has announced the reappointment of Ms. Kavita Bhansali as Executive Director for a further term of five years. The company has also proposed the voluntary winding up of its subsidiary, Bilcare INC, in the United States of America.

Gaudium IVF and Women Health Limited has informed the Exchange about Investor Presentation

The Board of Directors of AJR Infra And Tolling Ltd approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The results show a profit of Rs. 811.94 lakhs and a comprehensive income of Rs. 30,496.12 lakhs.

Panache Digilife Limited has received the Innovation & Excellence Award from Intel at the Industry Solution Builders Connect – 2026, held on August 13, 2026, in Bengaluru.

Brainbees Solutions Ltd has made available the audio-video recording of its earnings call for the quarter ended June 30, 2026, on its website.

Valecha Engineering Limited has reconstituted its Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee with new members.

Galaxy Surfactants Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, reporting a record quarterly EBITDA of ₹252.5 crore, a 86.9% YoY increase, and a PAT of ₹165.9 crore, a 108.7% YoY increase.

Apar Industries Ltd has allotted 16,88,618 equity shares to eligible qualified institutional buyers at ₹ 14,805 per share, increasing its paid-up equity share capital from ₹ 40,18,37,190 to ₹ 41,87,23,370.

Krsnaa Diagnostics Ltd has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, along with the approval of the Board of Directors for the issuance of 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited.

Godrej Consumer Products Limited has informed the Exchange about the schedule of an Analyst/Investor Meet, where the company's management will interact with analysts/investors on August 18, 2026, at 9:00 a.m. IST.